In 1993, the founders of Tennessee Oncology cultivated a new concept; to bring cancer research and clinical trials to the community instead of to large academic facilities. A close association with the Sarah Cannon Research Institute (SCRI) is key to achieving one of the largest community-based research networks in the country. Many Tennessee Oncology physicians are directors for SCRI, providing international leadership in several research programs. Through a collaboration with SCRI, both Tennessee Oncology clinics and patients gain access to cutting-edge clinical trials.
Read an impressive article in OncLive on Tennessee Oncology’s contribution and growth in clinical trials. This is why more physicians refer their patients to Tennessee Oncology than any other practice in Tennessee. Full article here.